{
    "clinical_study": {
        "@rank": "33383", 
        "arm_group": {
            "arm_group_label": "lasertrabeculoplasty", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as\n      or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment\n      strategy for glaucoma patients. It is done with a laser device that can also be used for\n      many other ophthalmic applications, thus reducing the economic burden of treatment."
        }, 
        "brief_title": "Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Open Angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  individuals over 18 years old\n\n          -  willing to sign an informed consent and able to comply the requirements of the study\n\n          -  having no other ocular diseases besides glaucoma\n\n        Exclusion Criteria:\n\n          -  history of ocular trauma\n\n          -  intraocular surgery (except for phaco)\n\n          -  pigment dispersion and exfoliation glaucoma"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788319", 
            "org_study_id": "S55194"
        }, 
        "intervention": {
            "arm_group_label": "lasertrabeculoplasty", 
            "intervention_name": "lasertrabeculoplasty", 
            "intervention_type": "Procedure", 
            "other_name": "Conventional (532nm)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "laser trabeculoplasty", 
            "glaucoma"
        ], 
        "lastchanged_date": "February 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium"
                }, 
                "name": "Department of Ophthalmology, UZLeuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients", 
        "overall_contact": {
            "last_name": "University Hospitals Leuven", 
            "phone": "+32 16 332372"
        }, 
        "overall_official": {
            "affiliation": "Universitaire Ziekenhuizen Leuven", 
            "last_name": "Evelien Vandewalle, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm)", 
            "safety_issue": "Yes", 
            "time_frame": "one year of follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788319"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Secondary the complication rate between the two techniques will be compared", 
            "safety_issue": "Yes", 
            "time_frame": "one year of follow up"
        }, 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}